Post-compression parameters of BCF floating tablets
FORMULATION AND EVALUATION OF FLOATING TABLETS OF METRONIDAZOLE
12
Formulation and Evaluation of Dexlansoprazole Floating Tablets
11
FORMULATION AND EVALUATION OF AMOXICILLIN FLOATING TABLETS
11
FORMULATION AND EVALUATION OF RANITIDINE FLOATING TABLETS
6
DESIGN AND CHARECTERISATION OF FLOATING TABLETS OF RANOLAZINE
5
Formulation and Evaluation of Simvastatin Floating Tablets
6
Formulation and Evaluation of Pantoprazole Sodium Floating Tablets
12
Formulation and Evaluation of Cefixime Floating Matrix Tablets
117
DESIGN AND IN VITRO CHARACTERIZATION OF FLOATING TABLETS OF METRONIDAZOLE
6
FORMULATION AND EVALUATION OF FLOATING EFFERVESCENT TABLETS OF RAMIPRIL
18
DEVELOPMENT AND IN VITRO EVALUATION OF PERINDOPRIL FLOATING TABLETS
12
FORMULATION AND IN VITRO EVALUATION OF FLOATING TABLETS OF TELMISARTAN
15
FORMULATION AND EVALUATION OF GASTRORETENTIVE CLARITHROMYCIN FLOATING TABLETS
13
FORMULATION AND EVALUATION OF CLOPIDOGREL BISULPHATE FLOATING TABLETS
11
Formulation and evaluation of gastroretentive floating tablets of rebamipide
10
Formulation and evaluation of olmesartan medoxomil floating tablets
6
FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF FLOATING TABLETS OF LAFUTIDINE BY DIRECT COMPRESSION METHOD
8
FLOATING TABLETS AND ITS POLYMERS
9
Design and Characterization of Floating Tablets of Ranolazine.
120
FORMULATION AND EVALUATION OF FLOATING TABLETS OF GABAPENTIN
7